Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016

Hedyeh Ebrahimi(City of Hope), Siamak Daneshmand(Unknown), Erfan Amini, Yasna Rostam‐Abadi(Tehran University of Medical Sciences), Farshad Farzadfar(Tehran University of Medical Sciences), Mohammad Reza Nowroozi(Tehran University of Medical Sciences), Peter C. Black(University of British Columbia), Arya Aminorroaya(Yale University), Behnam Nabavizadeh(Tehran University of Medical Sciences), Christina Fitzmaurice(Gundersen Health System), Sahar Saeedi Moghaddam(Kiel Institute for the World Economy), Farhad Pishgar
The Journal of Urology
January 25, 2019
10.1097/ju.0000000000000025
Cited by 121

Related Papers

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|13.6k
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.4k
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|6.7k
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|6.5k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k